Mass. Movers

Charles River’s 2013 forecast disappoints

Charles River’s business includes selling lab mice.

Globe file photo/2006

Charles River’s business includes selling lab mice.


Charles River Laboratories International Inc., which provices drug-research services, gave 2013 earnings guidance that was below Wall Street’s expectations. In addition, the Wilmington company now expects its 2012 per-share earnings to come in between the low end and the midpoint of its previously estimated range of $2.68 to $2.73. The company expects sales to grow by 3 to 5 percent next year, and that non-GAAP earnings per share would be in the range of $2.80 to $2.90. The analyst consensus for 2013 is $3.02, RTTNews reported.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of